Most cardiometabolic improvements reverted toward baseline
doi:10.1056/NEJMoa2411528 25
Results from additional trials are expected throughout 2026
Product safety is ensured through a rigorous system of 36 checkpoints and full-compliance testing according to international regulations (e.g., FDA, EU)
However, Mounjaro may be covered under some Medicare Part D or Medicare Advantage plans when prescribed for type 2 diabetes, since this is an FDA-approved indication
"So I don't think it's the end of it, but it certainly will bring us into a new era after the time period has passed and all the lawsuits are finished." Scott Brunner, CEO of the Alliance for Pharmacy Compounding, which represents compounding pharmacists and technicians, questioned whether the FDA took into account the number of patients who will need to transition from compounded drugs to FDA-approved versions before making its announcement